Non-Invasive Blood Glucose Monitoring Devices Market Size, Share, Outlook and Opportunity Analysis 2018-2026
Non-Invasive Blood Glucose Monitoring Devices Market |
Non-invasive glucose monitoring provides exceptional
guarantees for diabetes management by providing better and painless blood
glucose estimation, prompting the expansion of the non-invasive blood glucose
screen market in the anticipated time frame. These devices are used to estimate
blood glucose levels in diabetic patients without penetrating the skin or
causing pain or injury. The glucose monitoring device must track the regular
changes in blood glucose levels in diabetic patients. Glucose monitoring
devices can be invasive or non-invasive; however, the non-invasive blood
glucose monitoring devices market is expanding due to the need for a
cost-effective, compact, simple, and useful device for patients to use.
North America to
Dominate Global Non-invasive Blood Glucose Monitoring Devices Market
The global non-invasive blood glucose monitoring devices
market is divided into five regions: North America, Europe, Asia Pacific, Latin
America, and the Middle East and Africa.
North America led the global non-invasive
blood glucose monitoring devices market in terms of revenue in 2019,
followed by Europe. The region's large market share can be attributed to the
region's high disease prevalence and well-established health care
infrastructure, which allows for proper diagnosis. According to the American
Diabetes Association, 34.2 million Americans, or 10.5 percent of the
population, had diabetes in 2018. Furthermore, type 1 diabetes affects 1.6
million people, including approximately 187,000 children and adolescents.
However, the Asia Pacific market is expected to grow rapidly
during the forecast period, owing to an increase in diabetes prevalence and
increased awareness about diagnosis and treatment. The majority of Asia Pacific
countries are economically developing, and a number of major players are making
significant investments in the region. These factors contribute to the market's
expansion in Asia Pacific. According to the International Diabetes Federation
(IDF), diabetes prevalence has risen in developing countries as a result of
rapid and ongoing socioeconomic transition, and it is expected to rise further.
Comments
Post a Comment